You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Relapsed/Refractory Hepatoblastoma (HB)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatoblastoma, Hepatocellular Carcinoma (HCC), Liver Tumors Trial in Boston (ET140203 T Cells)

Recruiting
  • Hepatoblastoma
  • +5 more
  • ET140203 T Cells
  • Boston, Massachusetts
    Dana-Farber/Boston Children's Cancer and Blood Disorders Center
Aug 12, 2022

Relapsed Hepatoblastoma, Refractory Hepatoblastoma Trial in Cincinnati (Biospecimen collection)

Recruiting
  • Relapsed Hepatoblastoma
  • Refractory Hepatoblastoma
  • Biospecimen collection
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Sep 29, 2022

Ewing Sarcoma, Rhabdomyosarcoma, Wilms Tumor Trial in Valhalla (Vorinostat)

Recruiting
  • Ewing Sarcoma
  • +5 more
  • Valhalla, New York
    New York Medical College
Oct 24, 2022

Ototoxicity, Drug-Induced Trial in Cincinnati (Sodium Thiosulfate)

Recruiting
  • Ototoxicity, Drug-Induced
  • Sodium Thiosulfate
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Mar 6, 2023

Osteosarcoma, Ewing Sarcoma, Rhabdomyosarcoma Trial in Washington (Cryoablation Therapy, Nivolumab, Ipilimumab)

Recruiting
  • Osteosarcoma
  • +9 more
  • Cryoablation Therapy
  • +2 more
  • Washington, District of Columbia
    Children's National Hospital
Mar 21, 2022

Advanced Malignant Solid Tumor, Recurrent Childhood Ependymoma, Recurrent Ewing Sarcoma Trial in Puerto Rico, United States

Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • +31 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Birmingham, Alabama
  • +118 more
Jan 27, 2023

Advanced Malignant Solid Tumor, Ann Arbor Stage III Childhood Non-Hodgkin Lymphoma, Ann Arbor Stage IV Childhood Non-Hodgkin

Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • +35 more
  • Birmingham, Alabama
  • +113 more
Jun 28, 2022

Malignant Solid Tumor, Recurrent Ependymoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Trial in Puerto

Recruiting
  • Malignant Solid Neoplasm
  • +26 more
  • Birmingham, Alabama
  • +121 more
Aug 24, 2022

Advanced Malignant Solid Tumor, Recurrent Ependymoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Trial

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +30 more
  • Larotrectinib Sulfate
  • Birmingham, Alabama
  • +123 more
Aug 23, 2022

Hepatoblastoma, Carcinoma, Hepatocellular Trial in Aberdeen, Cambridge (Cisplatin, Doxorubicin, Carboplatin)

Recruiting
  • Hepatoblastoma
  • Carcinoma, Hepatocellular
  • Vienna, Austria
  • +30 more
Sep 5, 2022

Relapsed/Refractory Large Granular T Lymphocytic Leukemia Trial in Zhoukou, Tianjin (Linperlisib)

Not yet recruiting
  • Relapsed/Refractory Large Granular T Lymphocytic Leukemia
  • Zhoukou, Henan, China
  • +1 more
Dec 22, 2022

Advanced Malignant Solid Tumor, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial in

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +44 more
  • Biopsy
  • +23 more
  • Birmingham, Alabama
  • +166 more
Feb 2, 2023

Advanced Malignant Solid Tumor, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial in

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +32 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Birmingham, Alabama
  • +124 more
Aug 24, 2022

Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma Refractory, Non-Hodgkin's Lymphoma, Relapsed

Recruiting
  • Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia
  • +2 more
  • Autologous CAR19 T lymphocytes
  • Prague, Czechia
    Institute of Hematology and Blood Transfusion, Czech Republic
Aug 3, 2022

Pediatric Oncology Trial in Worldwide (Regorafenib (BAY73-4506), Vincristine (Cellcristin®), Irinotecan (Irinotecan Cell

Active, not recruiting
  • Pediatric Oncology
  • Regorafenib (BAY73-4506)
  • +2 more
  • Lyon, France
  • +11 more
Jan 16, 2023

MDS Trial in Worldwide (Talacotuzumab, Daratumumab)

Completed
Has Results
  • Myelodysplastic Syndromes
  • Saint Louis, Missouri
  • +20 more
Dec 28, 2022

Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia With Failed Remission Trial in São Paulo (Bortezomib)

Not yet recruiting
  • Acute Lymphoblastic Leukemia, in Relapse
  • Acute Lymphoblastic Leukemia With Failed Remission
  • São Paulo, SP, Brazil
    Instituto do Cancer do Estado de Sao Paulo
Sep 12, 2023

AML, Adult Recurrent, MDS Trial in United States (LYT-200)

Recruiting
  • AML, Adult Recurrent
  • MDS
  • Los Angeles, California
  • +13 more
Apr 12, 2023

Follicular Lymphoma, Diffuse Large B Cell Lymphoma, Marginal Zone Lymphoma Trial in France (Atezolizumab, Obinutuzumab,

Completed
  • Follicular Lymphoma
  • +3 more
  • Angers, France
  • +24 more
Jan 9, 2023

Hepatoblastoma, Radiology Trial in Shanghai

Recruiting
  • Hepatoblastoma
  • Radiology
    • Shanghai, Shanghai, China
      Department of Radiology, Renji Hospital, School of Medicine, Sha
    Feb 28, 2023

    Marginal Zone Lymphoma Trial in Tianjin (Obinutuzumab, lenalidomide)

    Recruiting
    • Marginal Zone Lymphoma
    • Obinutuzumab, lenalidomide
    • Tianjin, Tian, China
      Institute of Hematology & Blood Diseases Hospital
    Apr 27, 2023

    Brain Gliomas Trial in Suzhou (Allogenic B7H3 CAR-?dT cell)

    Recruiting
    • Brain Gliomas
    • Allogenic B7H3 CAR-γδT cell
    • Suzhou, Jiangsu, China
      Dushu Lake Hospital Affiliated to Soochow University
    Aug 25, 2023

    Transitional Cell Tumor, Hepatoblastoma, Liver Cancer Trial in Shanghai (PD-1 inhibitor)

    Not yet recruiting
    • Transitional Cell Tumor
    • +4 more
    • PD-1 inhibitor
    • Shanghai, China
      Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong Universi
    Apr 3, 2022

    Peripheral T Cell Lymphoma Trial in Beijing (Linperlisib in combined with Chidamide)

    Recruiting
    • Peripheral T Cell Lymphoma
    • Linperlisib in combined with Chidamide
    • Beijing, Beijing/China, China
    • +1 more
    Oct 9, 2023

    Non-hodgkin's Lymphoma Trial in Beijing (GNC-035)

    Not yet recruiting
    • Non-hodgkin's Lymphoma
    • Beijing, Beijing, China
      Beijing Cancer Hospital
    Sep 27, 2023